JPMorgan Chase & Co’s AnaptysBio ANAB Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | $5.5M | Buy |  | |||||
| 2025 Q1 | $266K | Sell |  | |||||
| 2024 Q4 | $1.52M | Buy |  | |||||
| 2024 Q3 | $1.13M | Buy |  | |||||
| 2024 Q2 | $290K | Sell |  | |||||
| 2024 Q1 | $301K | Sell |  | |||||
| 2023 Q4 | $375K | Sell |  | |||||
| 2023 Q3 | $510K | Buy |  | |||||
| 2023 Q2 | $559K | Sell |  | |||||
| 2023 Q1 | $4.65M | Sell |  | |||||
| 2022 Q4 | $6.63M | Sell |  | |||||
| 2022 Q3 | $5.73M | Sell |  | |||||
| 2022 Q2 | $4.7M | Sell |  | |||||
| 2022 Q1 | $5.8M | Sell |  | |||||
| 2021 Q4 | $8.21M | Sell |  | |||||
| 2021 Q3 | $6.65M | Sell |  | |||||
| 2021 Q2 | $7.95M | Sell |  | |||||
| 2021 Q1 | $6.96M | Buy |  | |||||
| 2020 Q4 | $6.48M | Buy |  | |||||
| 2020 Q3 | $3.79M | Sell |  | |||||
| 2020 Q2 | $6.22M | Sell |  | |||||
| 2020 Q1 | $4.4M | Sell |  | |||||
| 2019 Q4 | $6.88M | Buy |  | |||||
| 2019 Q3 | $2.05M | Buy |  | |||||
| 2019 Q2 | $3.06M | Buy |  | |||||
| 2019 Q1 | $3.99M | Sell |  | |||||
| 2018 Q4 | $3.49M | Buy |  | |||||
| 2018 Q3 | $5.22M | Sell |  | |||||
| 2018 Q2 | $9.02M | Buy |  | |||||
| 2018 Q1 | $5.33M | Sell |  | |||||
| 2017 Q4 | $7.12M | Sell |  | |||||
| 2017 Q3 | $6.36M | Buy |  | |||||
| 2017 Q2 | $1.41M | Sell |  | |||||
| 2017 Q1 | $3.85M | Buy |  | 
